Literature DB >> 12761205

CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation.

Takaho Endo1, Atsuo Sasaki, Mayu Minoguchi, Akiko Joo, Akihiko Yoshimura.   

Abstract

Prolactin (PRL) interacts with a single-chain prolactin-specific receptor of the cytokine receptor superfamily. PRL triggers the activation of JAK2 kinase, which phosphorylates the PRL receptor itself, and of STAT5, a member of the family of signal transducers and activators of transcription (STAT). We have shown that the STAT5-dependent immediate early gene, CIS1 (Cytokine-Inducible SH2 domain-containing protein-1), suppresses PRL-induced STAT5 activation in vitro as well as in transgenic mice. To facilitate the study of the interactions between CIS1 and the PRL receptor, we have developed the yeast tri-hybrid system, a modification of the yeast two-hybrid system. We expressed CIS1 fused to the DNA-binding domain and PRL receptor cytoplasmic domain fused to the transcription activation domain in the presence or absence of the tyrosine kinase domain of JAK2 in yeast. CIS1 bound to the PRL receptor cytoplasmic domain in a JAK2-dependent manner. Moreover, we determined that the phosphorylated Y532 of the murine PRL receptor is the binding site for CIS1. Interestingly, Y532 has been shown to be unnecessary for STAT5 activation, although CIS1 overexpression suppressed PRL-induced STAT5 activation. These data suggest that the suppression of STAT5 activation by CIS1 is not due to a simple competition with STAT5 but rather to a modification of the receptor by CIS1 binding.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761205     DOI: 10.1093/jb/mvg004

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  13 in total

1.  The transcriptional response of the islet to pregnancy in mice.

Authors:  Sebastian Rieck; Peter White; Jonathan Schug; Alan J Fox; Olga Smirnova; Nan Gao; Rana K Gupta; Zhao V Wang; Philipp E Scherer; Mark P Keller; Alan D Attie; Klaus H Kaestner
Journal:  Mol Endocrinol       Date:  2009-07-02

Review 2.  Negative Regulation of Cytokine Signaling in Immunity.

Authors:  Akihiko Yoshimura; Minako Ito; Shunsuke Chikuma; Takashi Akanuma; Hiroko Nakatsukasa
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-07-02       Impact factor: 10.005

Review 3.  Suppression of cytokine signaling: the SOCS perspective.

Authors:  Edmond M Linossi; Jeffrey J Babon; Douglas J Hilton; Sandra E Nicholson
Journal:  Cytokine Growth Factor Rev       Date:  2013-03-30       Impact factor: 7.638

4.  Regulation of cytokine-inducible SH2-containing protein (CIS) by ubiquitination and Elongin B/C interaction.

Authors:  Philip J Jensik; Lydia A Arbogast
Journal:  Mol Cell Endocrinol       Date:  2014-11-04       Impact factor: 4.102

Review 5.  Expansion of beta-cell mass in response to pregnancy.

Authors:  Sebastian Rieck; Klaus H Kaestner
Journal:  Trends Endocrinol Metab       Date:  2009-12-16       Impact factor: 12.015

Review 6.  SOCS regulation of the JAK/STAT signalling pathway.

Authors:  Ben A Croker; Hiu Kiu; Sandra E Nicholson
Journal:  Semin Cell Dev Biol       Date:  2008-07-30       Impact factor: 7.727

7.  Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.

Authors:  Yasuko Hirata; Hilde Brems; Mayu Suzuki; Mitsuhiro Kanamori; Masahiro Okada; Rimpei Morita; Isabel Llano-Rivas; Toyoyuki Ose; Ludwine Messiaen; Eric Legius; Akihiko Yoshimura
Journal:  J Biol Chem       Date:  2015-12-03       Impact factor: 5.157

Review 8.  Targeting Oncogenic Transcription Factors: Therapeutic Implications of Endogenous STAT Inhibitors.

Authors:  Lisa N Heppler; David A Frank
Journal:  Trends Cancer       Date:  2017-11-10

9.  CISH has no non-redundant functions in glucose homeostasis or beta cell proliferation during pregnancy in mice.

Authors:  Yang Jiao; Sebastian Rieck; John Le Lay; Klaus H Kaestner
Journal:  Diabetologia       Date:  2013-08-16       Impact factor: 10.122

10.  Suppressor of cytokine signaling 4 (SOCS4) protects against severe cytokine storm and enhances viral clearance during influenza infection.

Authors:  Lukasz Kedzierski; Edmond M Linossi; Tatiana B Kolesnik; E Bridie Day; Nicola L Bird; Benjamin T Kile; Gabrielle T Belz; Donald Metcalf; Nicos A Nicola; Katherine Kedzierska; Sandra E Nicholson
Journal:  PLoS Pathog       Date:  2014-05-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.